tm
Seeing Is Believing
tm
Seeing Is Believing
Cyclacel Pharmaceuticals's activity chart (see below) currently has 3 price targets and 4 ratings on display.
Analysts average stock forecasts to be materialized ratio is 86.67% with an average time for these price targets to be met of 350.6 days.
Most recent stock forecast was given by JONATHAN ASCHOFF from ROTH MKM on 03-May-2024. First documented stock forecast 27-Apr-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Apr-2020
$176
$169.63 (2662.95%)
$336
2 years 4 months 5 days ago
(03-May-2024)
3/3 (100%)
$-51.63 (-22.68%)
60
Buy
$8
$5.1 (175.86%)
$10
3 years 3 months 14 days ago
(25-May-2023)
3/3 (100%)
$-2.05 (-20.40%)
30
Buy Since 19-May-2020
$5280
3 years 6 months 1 days ago
(07-Mar-2023)
1/1 (100%)
$-2180.71 (-29.23%)
615
Buy Since 13-May-2020
$4080
$4073.63 (63950.24%)
4 years 1 months 21 days ago
(18-Jul-2022)
2/3 (66.67%)
$1928.86 (89.67%)
524
What is CYCC (Cyclacel Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on CYCC (Cyclacel Pharmaceuticals)?
Which analyst has the current lower performing score on CYCC (Cyclacel Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on CYCC (Cyclacel Pharmaceuticals)?
Which analyst is the currently most bullish on CYCC (Cyclacel Pharmaceuticals)?
Which analyst is the currently most reserved on CYCC (Cyclacel Pharmaceuticals)?
